Use of botulinum toxin for movement disorders

Carlos Henrique Ferreira Camargo MD, MSc, PhD, Hélio Afonso Ghizoni Teive MD, MSc, PhD


The term movement disorders encompasses all disorders hypokinetic and hyperkinetic, which were previously known as extrapyramidal syndromes. With the definition of movement disorders and their diagnostic criteria and classifications, new studies for therapeutics could be performed. New drugs were launched, functional neurosurgery was developed, and the introduction of botulinum toxin (BoNT) for hyperkinesias was introduced. BoNT is an important therapy for dystonia, tics, myoclonus, and tremors. The aim of this review is to present the new and well-established uses of BoNT for movement disorders.

Article Details

Article Type





Publication Dates

Accepted: ; Published: .


Camargo CHF, Teive HAG. Use of botulinum toxin for movement disorders. Drugs in Context 2019; 8: 212586. DOI: 10.7573/dic.212586

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.